Predictors of hematologic response and survival with stem cell transplantation in <scp>AL</scp> amyloidosis: A 25‐year longitudinal study-Reference-Cited by-同舟云学术

Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25‐year longitudinal study

Published:2022-07-05 Issue:9 Volume:97 Page:1189-1199
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Gustine Joshua N.¹^ORCID,Staron Andrew¹²^ORCID,Szalat Raphael E.¹²^ORCID,Mendelson Lisa M.¹²^ORCID,Joshi Tracy¹²^ORCID,Ruberg Frederick L.¹³^ORCID,Siddiqi Omar¹³^ORCID,Gopal Deepa M.¹³^ORCID,Edwards Camille V.¹²^ORCID,Havasi Andrea¹⁴^ORCID,Kaku Michelle¹⁵^ORCID,Lau K. H. Vincent¹⁵^ORCID,Berk John L.¹⁶^ORCID,Sloan J. Mark¹²^ORCID,Sanchorawala Vaishali¹²^ORCID

Affiliation:

1. Amyloidosis Center Boston University School of Medicine and Boston Medical Center Boston Massachusetts USA

2. Section of Hematology and Medical Oncology Boston University School of Medicine and Boston Medical Center Boston Massachusetts USA

3. Section of Cardiovascular Medicine Boston University School of Medicine and Boston Medical Center Boston Massachusetts USA

4. Section of Nephrology Boston University School of Medicine and Boston Medical Center Boston Massachusetts USA

5. Section of Neurology Boston University School of Medicine and Boston Medical Center Boston Massachusetts USA

6. Section of Pulmonology Boston University School of Medicine and Boston Medical Center Boston Massachusetts USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26641

Reference49 articles.

1. Systemic immunoglobulin light chain amyloidosis

2. Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients

3. High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study

4. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

5. Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system;American Journal of Hematology;2024-08-29

2. Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and Outcomes;Clinical Lymphoma Myeloma and Leukemia;2024-08

3. Autologous stem cell transplantation in AL amyloidosis: Muddy waters;Blood Reviews;2024-08

4. Treatment of AL amyloidosis in the era of novel immune and cellular therapies;Frontiers in Oncology;2024-06-28

5. Systemic Light Chain Amyloidosis;New England Journal of Medicine;2024-06-27